ClinicalTrials.gg
CompletedNCT03865524Updated Sep 25, 2026

Effect Of The Use Of Navigation In The Alignment Obtained When Performing A Total Knee Arthroplasty In Obese Patients

An interventional study of Total knee arthroplasty implanted with GPS navigation system and Total knee arthroplasty implanted with standard guides. in Osteoarthritis, Knee, Obesity and Arthropathy of Knee, sponsored by Pedro-José Torrijos-Garrido. Completed at 2 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Pedro-José Torrijos-Garrido · Not applicable, Interventional, and Treatment

How we know

Updated Sep 25, 2026Now CompletedResults publication added+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
159
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 100 studies in Osteoarthritis, Knee with a site in Spain — 16 open to participants now, 19 under way, 3 of them phase 3. Osteoarthritis, Knee · Spain.

Enrollment
27th of 86
159 · median 100
Started
2019
with 6 others
No phase
47 of 100
12 open now
Registered
52nd of 100
by date

Among the 100 studies in Osteoarthritis, Knee with a site in Spain, this one is the 27th largest by enrollment of the 86 interventional ones that give a count, is one of 7 that started in 2019, is one of 47 with no phase, and was the 52nd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

16 of the 100 studies in Osteoarthritis, Knee with a site in Spain are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 100 studies in Osteoarthritis, Knee with a site in Spain, or all of them as a file.
02

Study summary

NAOBE is a randomized, open and prospective clinical trial that evaluates the accuracy to achieve an adequate mechanical axis of the lower extremity in obese patients after total knee replacement.

Read the detailed description

Randomized, open and prospective clinical trial.

Following the surgical indication for a total knee replacement as treatment for symptomatic osteoarthritis and the confirmation of obesity (BMI equal or greater than 30 Kg/m2 ), patients will be randomly assigned (ratio 1:1) to one of the following treatments:

Control group: Total knee arthroplasty implanted with standard guides . Experimental group: Total knee arthroplasty(TKA) implanted with GPS navigation system Patient (or their legal guardian) must provide/sign the informed consent prior to inclusion in the study.

After the surgery, patients will be followed-up at 6 weeks, 3, 6 and 12 months. At those times, data regarding physical and radiological examinations, pain and functionality and health status questionnaires will be collected.

03

Conditions studied

  • Osteoarthritis, Knee
  • Obesity
  • Arthropathy of Knee

Keywords

  • Osteoarthritis, Knee
  • Obesity
  • Knee replacement
  • Arthroplasty
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women over 18 years old.
  • Written according to ICH / GCP and Spanish legislation, obtained before any study procedure.
  • Patient with a equal to or greater than 30 Kg / m2
  • Patients with clinical and radiological criteria of knee osteoarthritis.
  • Patients with indication for primary TKA according to medical criteria.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or lactation.
  • Inability to give in the absence of a legal representative.
  • Subjects that are participating in a study with medicines or other medical devices.
  • Those who show inability to follow the instructions or collaborate during the development of the study.
  • If in the opinion of the researcher there are findings in the physical examination, abnormalities in the results of the clinical analyzes or other medical, social or psychosocial factors that could have a negative influence
  • Having had a previous surgical procedure on or around the knee in the last 12 months (such as proximal tibial osteotomy, femoral osteotomy, open reduction and internal fixation for a fracture, patellectomy or patellar realignment).
  • Need a simultaneous bilateral TKA.
  • Have a varus angle or valgus ≥ 15 °.
  • Total revision knee arthroplasty.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
159 participants (actual)

Study arms

  • Experimental
    Experimental

    Total knee arthroplasty implanted with GPS navigation system.

    Device: Total knee arthroplasty implanted with GPS navigation system

  • Active comparator
    Control

    Total knee arthroplasty implanted with standard guides.

    Device: Total knee arthroplasty implanted with standard guides.

Interventions

  • DeviceTotal knee arthroplasty implanted with GPS navigation system

    Obese patients undergoing Total Knee Arthroplasty, GPS achieved alignment

  • DeviceTotal knee arthroplasty implanted with standard guides.

    Obese patients undergoing Total Knee Arthroplasty, alignment achieved by using standard guides

06

What researchers measure

Primary outcomes

  1. Deviation in a mechanical axis of knees

    Proportion of knees after surgery with a mechanical axis with a deviation greater than 3º

    Time frame: 12 months

Secondary outcomes

  1. Radiological axes (femoral)

    Position angle of the femoral component: angle formed between the anatomical axis of the femur and the articular surface of the femoral component of the TKA (α).

    Time frame: 12 months

  2. Radiological axes (tibial)

    Position angle of the tibial component: angle formed between the anatomical axis of the tibia and the proximal surface of the tibial component of the TKA (β).

    Time frame: 12 months

  3. Surgical procedure time

    Surgical time

    Time frame: Week 1

  4. Admission (hospital) duration

    Number of days of the hospital admission

    Time frame: Week 1

  5. Number of Surgical complications (Intraoperative)

    Intraoperative complications

    Time frame: Week 1

  6. Number of Surgical complications (perioperative)

    perioperative complications

    Time frame: 1 to 6 weeks

  7. Number of Surgical complications (post-operative)

    postoperative complications

    Time frame: 1-12 months

Other outcomes

  1. Knee Society Score Questionaire

    KSS Questionaire, developed by the Knee Society, assesses the function of the knee replacement and the functional capabilities of patients after their implantation. It has to separate sections ("Knee Score" and "Functional Score") that are scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.

    Time frame: 6 weeks-12 months

  2. Range of Motion

    The maximum extension and flexion

    Time frame: 6 weeks-12 months

  3. Visual Analogic Scale for pain

    VAS measure the intensity of the pain that the patient describes. It consists of a horizontal line of 10 centimeters, with 0cm being "no pain" and 10cm being "extreme pain".

    Time frame: 1-12 months

07

Study locations

2 sites
  • Hospital Universitario Santa Cristina
    Madrid, Madrid 28009, Spain
  • Hospital Universitario Puerta de Hierro Majadahonda
    Majadahonda, Madrid 28222, Spain
08

References and documents

Publications

  • Zurron Lobato M, Bartolome Garcia S, Aragones Maza P, Valverde Villar A, Ramirez Feito C, Gonzalez Gonzalez MS, Payares Herrera MC, Fernandez de Pedro SP, Jimenez Martin J, Torrijos Garrido PJ. The Use of Navigation During Total Knee Replacement Improves Precision in Achieving Mechanical Alignment in Obese Patients: A Short-Term Multicenter Randomized Clinical Trial. JB JS Open Access. 2025 Oct 22;10(4):e25.00220. doi: 10.2106/JBJS.OA.25.00220. eCollection 2025 Oct-Dec. PubMed 41112698 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2019 to primary completion in Nov 2024, 68 months.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 68 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 25, 2026: primary completion Jun 2024 → Nov 2024 and completion Jun 2024 → Nov 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2019
First posted
Mar 7, 2019
StartActual
Feb 7, 2019
Primary completionActual
Nov 6, 2024was Jun 2024
CompletionActual
Nov 6, 2024was Jun 2024
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Sep 25, 2026
Sites
1 site added, 1 site removed
Show site
  • Hospital Universitario Santa Cristina · Madrid, Spain
Show 1 removed
  • Hospital Universitario Santa Cristina · Madrid, Spain
Sep 25, 2026
Primary completion
Jun 30, 2024→Nov 6, 2024 (actual)
Sep 25, 2026
Study completion
Jun 30, 2024→Nov 6, 2024 (actual)
Sep 25, 2026
Enrollment
158 (estimated)→159 (actual)
Sep 25, 2026
Publications
Results publication added: Zurron Lobato M, Bartolome Garcia S, Aragones Maza P, Valverde Villar A, Ramirez Feito C, Gonzalez Gonzalez MS, Payares Herrera MC, Fernandez de Pedro SP, Jime… PubMed 41112698 ↗
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Recruiting→Completed
    Publications Results publication added: Zurron Lobato M, Bartolome Garcia S, Aragones Maza P, Valverde Villar A, Ramirez Feito C, Gonzalez Gonzalez MS, Payares Herrera MC, Fernandez de Pedro SP, Jime… PubMed 41112698 ↗
    1 site added, 1 site removed
    Show site
    • Hospital Universitario Santa Cristina · Madrid, Spain
    Show 1 removed
    • Hospital Universitario Santa Cristina · Madrid, Spain
    Primary completion Jun 30, 2024→Nov 6, 2024 (now actual)
    Study completion Jun 30, 2024→Nov 6, 2024 (now actual)
    Enrollment 158 (estimated)→159 (actual)
    + 3 other changes: verification date, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03865524
Lead sponsor
Pedro-José Torrijos-Garrido
Responsible party
Pedro-José Torrijos-Garrido (Principal Investigator, Puerta de Hierro University Hospital) — Sponsor-investigator
First posted
Mar 7, 2019
Start date
Feb 7, 2019
Primary completion
Nov 6, 2024
Completion
Nov 6, 2024
Last update
Sep 25, 2026

Study contacts

Pedro José Torrijos Garrido, MD, PhD
principal investigator · Hospital Universitario Puerta de Hierro

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion